Creating an Aligned Care Plan in HIV, Oncology

Video

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses HIV and oncology distinction programs and how these standards bring patients, physicians, and pharmacists together to align care.

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses HIV and oncology distinction programs and how these standards bring patients, physicians, and pharmacists together to align care.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Physician and kidneys
Image credit: gamjai - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Related Content
Health care professional administering a vaccine

Vaccination Status of Patients with Hematologic Malignancies Not Correlated with Severity of COVID-19 Infection

November 28th 2023
Article
Independent Rx Forum: NCPA Priorities, Legislative Updates for Independent Pharmacies

Independent Rx Forum: NCPA Priorities, Legislative Updates for Independent Pharmacies

November 28th 2023
Podcast
3D illustration of HIV

Antibodies That Can Prevent HIV-1 Infection Remain Detectable Even at Low Antigen Levels

November 28th 2023
Article
Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze

Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze

November 13th 2023
Podcast
Doctor writing word Lymphoma with marker, Medical concept | Image Credit: MP Studio - stock.adobe.com

FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma

November 28th 2023
Article
Woman checking an abnormal mole

Study Indicates Potential of Pembrolizumab in Advanced Melanoma

November 27th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.